Catalyst Wire Dossier Catalyst Wire Dossier

RenalGuard

· CardioRenal Systems, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RenalGuard, covering 2016-09-05 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI [NA]

See pricing